LATEST NEWS

Uromedica at SMSNA

Come visit us at SMSNA 2023 in San Diego, CA

Uromedica at the Western Section of the AUA

Come visit us at the Western Section of the AUA in Lake Tahoe, CA

Uromedica at Urology Today

Come visit us at Urology Today in Asheville, NC

Uromedica at NCSAUA

Come visit us at the North Central Section of the AUA in Scottsdale, AZ

Uromedica at ICS 2023

Come visit us at the International Continence Society in Toronto!

Uromedica at AUA 2023

Come visit Uromedica at the American Urological Association's 2023 Annual Meeting (AUA) , Booth 4025, April 28-1st

Uromedica at EAU 2023

Come visit Uromedica in Milan on March 10-13 at the European Association of Urology (EAU) meeting, Booth A05.

Uromedica at AUA 2022

Come visit Uromedica at Booth 2719 in New Orleans for the American Urological Association (AUA) meeting!

New ProACT Paper: Bada et al

New OUS ProACT Paper: ProACT in the management of stress urinary incontinence after radical prostatectomy. What happens after 8 years of follow up? Monocentric analysis in 42 patients.

New CPT-I codes for ProACT

Four new Category I CPT codes have been assigned to ProACT™ Adjustable Continence Therapy for Men and will be effective January 1st, 2022.

Uromedica at AUA 2021

Come visit Uromedica at Booth 431 in Las Vegas for the American Urological Association (AUA) meeting!

First Patients Enrolled in ACT Trial

First Patients Enrolled in Uromedica’s Adjustable Continence Therapy (ACT®) for Female Stress Urinary Incontinence (SUI) Trial

New ProACT Surgical Video

New surgical video for the ProACT Adjustable Continence Therapy for Men.

New ProACT Animation

New animation on the ProACT Adjustable Continence Therapy for Men procedure.

New ProACT Paper: Munier et al

New OUS ProACT Paper: What if artificial urinary sphincter is not possible? Feasibility and effectiveness of ProACT for patients with persistent stress urinary incontinence after radical prostatectomy treated by sling

ACT Clinical Trial

FDA Approval on the Protocol for the Clinical Investigation on the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence

ProACT receives French National Reimbursement

ProACT is now listed on the LPPR register and reimbursed in France.

New ProACT Paper: Larson et al

New USA ProACT Paper: Adjustable continence therapy (ProACT) for the treatment of male stress urinary incontinence: A systematic review and meta-analysis

New ProACT Paper: Nash et al

New USA ProACT Paper: Treatment with an adjustable long-term implant for post-prostatectomy stress incontinence: The ProACT™ pivotal trial.

First US Commercial Implant of ProACT

Uromedica Announces Successful First US Commercial Implant of ProACT™ Adjustable Continence Therapy for Men